News

September 2, 2024

July 17, 2024

June 17, 2024

Kinea Selected for Fast-Track NIH Small Business Innovation Research Funding

April 19, 2024

Jeffrey Chamberlain, Co-founder, Interviewed on MDA Quest Podcast

April 17, 2024

Kinea Bio Presents at Life Science Innovation Northwest Annual Conference

April 1, 2024

Parent Project Muscular Dystrophy Funds Kinea Bio

February 13, 2024

Jeffrey Chamberlain, Co-founder, Receives Muscular Dystrophy Association Legacy Award

January 30, 2024

Jeffrey Chamberlain, Co-founder, Elected President of American Society for Gene and Cell Therapy

May 20, 2023

Hichem Tasfaout, Contributing Scientist, Presents at Prestigious ASGCT Presidential Symposium at Annual ASGCT Meeting

May 18, 2023

The Speak Foundation Funds Kinea Bio

June 2, 2022

CureLGMD2i Funds Kinea Bio

May 10, 2022

Chief Operating Officer Seung Wook Oh, PhD authors review article on non-viral gene therapy delivery for Duchenne Muscular Dystrophy

A Breakthrough Gene Therapy Strategy for Kinea's Lead Program, DMD, Published in Nature

Kinea Awarded Pilot Grant by University of Washington’s Center for Translational Muscle Research